Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

  • Filters activated: Cancer. Clear all to show 271 items.
1.

Tretinoin-loaded liposomal formulations: from lab to comparative clinical study in acne patients.

Rahman SA, Abdelmalak NS, Badawi A, Elbayoumy T, Sabry N, El Ramly A.

Drug Deliv. 2016 May;23(4):1184-93. doi: 10.3109/10717544.2015.1041578. Epub 2015 May 25. Erratum in: Drug Deliv. 2016 Oct;23 (8):3180.

PMID:
26004128
2.

Enhanced permeability across Caco-2 cell monolayers by specific mannosylating ligand of buserelin acetate proliposomes.

Yingsukwattana K, Puttipipatkhachorn S, Ruktanonchai U, Sarisuta N.

J Liposome Res. 2016;26(1):69-79. doi: 10.3109/08982104.2015.1039030. Epub 2015 May 6.

PMID:
25945393
3.

Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.

Abdelbary AA, AbouGhaly MH.

Int J Pharm. 2015 May 15;485(1-2):235-43. doi: 10.1016/j.ijpharm.2015.03.020. Epub 2015 Mar 12.

PMID:
25773359
4.

[Comparative study of pharmacokinetics of ofloxacin in a free and niosomal forms in experiments on white mice when administered per os].

Kulichenko AN, Mikhań≠lova ME, Kovalev DA, Pisarenko SV, Siritsa IuV, Liapustina LV.

Vestn Ross Akad Med Nauk. 2014;(1-2):80-4. Russian.

PMID:
25055566
5.

Preparation of vesicles entrapped lycopene extract.

Luxsuwong D, Indranupakorn R, Wongtrakul P.

J Oleo Sci. 2014;63(6):645-52. Epub 2014 May 15.

6.

PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.

Lin T, Fang Q, Peng D, Huang X, Zhu T, Luo Q, Zhou K, Chen W.

Drug Deliv. 2013 Sep-Oct;20(7):277-84. doi: 10.3109/10717544.2013.836618.

PMID:
24044645
7.

Formulation and characterization of nanoliposomal 5-fluorouracil for cancer nanotherapy.

Elmeshad AN, Mortazavi SM, Mozafari MR.

J Liposome Res. 2014 Mar;24(1):1-9. doi: 10.3109/08982104.2013.810644. Epub 2013 Jul 8.

PMID:
23834067
8.

Systemic delivery of small interfering RNA by use of targeted polycation liposomes for cancer therapy.

Kenjo E, Asai T, Yonenaga N, Ando H, Ishii T, Hatanaka K, Shimizu K, Urita Y, Dewa T, Nango M, Tsukada H, Oku N.

Biol Pharm Bull. 2013;36(2):287-91.

9.

[In vivo imaging of liposomal small interfering RNA (siRNA) trafficking by positron emission tomography].

Ando H, Yonenaga N, Asai T, Hatanaka K, Koide H, Tsuzuku T, Harada N, Tsukada H, Oku N.

Yakugaku Zasshi. 2012;132(12):1373-81. Review. Japanese.

10.

RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment.

Yonenaga N, Kenjo E, Asai T, Tsuruta A, Shimizu K, Dewa T, Nango M, Oku N.

J Control Release. 2012 Jun 10;160(2):177-81. doi: 10.1016/j.jconrel.2011.10.004. Epub 2011 Oct 13.

PMID:
22019557
11.

Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery.

Asai T, Matsushita S, Kenjo E, Tsuzuku T, Yonenaga N, Koide H, Hatanaka K, Dewa T, Nango M, Maeda N, Kikuchi H, Oku N.

Bioconjug Chem. 2011 Mar 16;22(3):429-35. doi: 10.1021/bc1004697. Epub 2011 Mar 1.

PMID:
21361311
12.

Ciprofloxacin liposomes as vesicular reservoirs for ocular delivery: formulation, optimization, and in vitro characterization.

Mehanna MM, Elmaradny HA, Samaha MW.

Drug Dev Ind Pharm. 2009 May;35(5):583-93. doi: 10.1080/03639040802468024.

PMID:
19031311
13.
14.
17.

Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.

Manconi M, Sinico C, Valenti D, Lai F, Fadda AM.

Int J Pharm. 2006 Mar 27;311(1-2):11-9. Epub 2006 Jan 24.

PMID:
16439071
18.

Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol.

Fang JY, Hwang TL, Huang YL, Fang CL.

Int J Pharm. 2006 Mar 9;310(1-2):131-8. Epub 2006 Jan 18.

PMID:
16413711
19.
20.

Supplemental Content

Loading ...
Support Center